HEALTHX.NS
HEALTHX · Capital Goods · NSE
₹280
Current Market Price
Fair Value (DCF)
₹112
Margin of Safety
-60.1%
Updated just now
YieldIQ Score
35/100
Piotroski F-Score
3/9
Economic Moat
Narrow
Confidence
119%
ROE
-13.6%
Debt/Equity
0.01
WACC
11.1%
Market Cap
₹892 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
-29.5%
Return on capital employed
EV / EBITDA
—
Enterprise multiple
Debt / EBITDA
1.1×
Leverage vs earnings
Interest Coverage
—
EBIT covers interest
Current Ratio
—
Short-term liquidity
Asset Turnover
1.12×
Revenue per ₹ of assets
Revenue CAGR (3Y)
20.1%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹280.4
Bear case
₹4.34
MoS -6360.8%
Base case
₹111.93
MoS -150.5%
Bull case
₹134.32
MoS -108.8%
Ratio Trends
HEALTHX · last 4 annual periods
ROE
-13.6%
ROCE
-29.5%
Operating Margin
—
Debt / Equity
0.00×
PE
—
EV / EBITDA
—
Historical Financials
HEALTHX · Annual, last 4 years· amounts in ₹Cr unless noted
| Metric | 2022 yfinance | 2023 yfinance | 2024 yfinance | 2025 yfinance | CAGR |
|---|---|---|---|---|---|
| Revenue | ₹630 Cr | ₹1038 Cr | ₹1356 Cr | ₹1090 Cr | +20.0% |
| EBITDA | ₹1115 Cr | ₹-113 Cr | ₹-20.4 Cr | ₹-198 Cr | — |
| EBIT | — | — | — | — | — |
| PAT | ₹627 Cr | ₹-72.2 Cr | ₹8.9 Cr | ₹-91.2 Cr | — |
| EPS (diluted) | — | — | — | — | — |
| CFO | ₹-207 Cr | ₹-112 Cr | ₹35.9 Cr | ₹-17.3 Cr | — |
| CapEx | ₹-4.7 Cr | ₹-19.5 Cr | ₹-14.2 Cr | ₹-10.4 Cr | — |
| FCF | ₹-212 Cr | ₹-131 Cr | ₹21.6 Cr | ₹-27.7 Cr | — |
| Total Assets | ₹1278 Cr | ₹1206 Cr | ₹1150 Cr | ₹974 Cr | -8.6% |
| Total Debt | ₹1.9 Cr | ₹9.3 Cr | ₹3.9 Cr | ₹0.9 Cr | -20.9% |
| Shareholders' Equity | ₹827 Cr | ₹753 Cr | ₹762 Cr | ₹670 Cr | -6.8% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
Peers not yet ranked for HEALTHX. Comparable companies and side-by-side valuation will appear here once the peer set is established.
Dividend History
No dividend events recorded for HEALTHX in the last 10 years.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of HEALTHX →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for HEALTHX →
Compare
Head-to-head with peers
Compare HEALTHX side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse HEALTHXNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.